0001022079-17-000151.txt : 20170621 0001022079-17-000151.hdr.sgml : 20170621 20170621162804 ACCESSION NUMBER: 0001022079-17-000151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170619 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Jon R CENTRAL INDEX KEY: 0001477972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 17923137 MAIL ADDRESS: STREET 1: C/O QUEST DIAGNOSTICS INCORPORATED STREET 2: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 wf-form4_149807686777487.xml FORM 4 X0306 4 2017-06-19 0 0001022079 QUEST DIAGNOSTICS INC DGX 0001477972 Cohen Jon R C/O QUEST DIAGNOSTICS 3 GIRALDA FARMS MADISON NJ 07940 0 1 0 0 SVP & Group Exec. Diag. Sol. Common Stock 2017-06-19 4 M 0 13680 57.605 A 86863 D Common Stock 2017-06-19 4 M 0 29340 56.12 A 116203 D Common Stock 2017-06-19 4 M 0 63880 52.165 A 180083 D Common Stock 2017-06-19 4 S 0 13344 107.52 D 166739 D Common Stock 2017-06-19 4 S 0 336 108.149 D 166403 D Common Stock 2017-06-19 4 S 0 28182 107.527 D 138221 D Common Stock 2017-06-19 4 S 0 1158 108.137 D 137063 D Common Stock 2017-06-19 4 S 0 61321 107.529 D 75742 D Common Stock 2017-06-19 4 S 0 2559 108.134 D 73183 D Stock Options (Right to Buy) 57.605 2017-06-19 4 M 0 13680 57.605 D 2022-02-27 Common Stock 13680.0 0 D Stock Options (Right to Buy) 56.12 2017-06-19 4 M 0 29340 56.12 D 2023-02-25 Common Stock 29340.0 0 D Stock Options (Right to Buy) 52.165 2017-06-19 4 M 0 63880 52.165 D 2024-02-13 Common Stock 63880.0 0 D This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 16, 2017. This transaction was executed in multiple trades at prices ranging from $107.12 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $108.14 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $108.12 to $108.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $108.12 to $108.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The options vested in three annual installments beginning with the first on February 27, 2012, the second February 27, 2013 and the final on February 27, 2014. The options vested in three annual installments beginning with the first on February 25, 2013 the second on February 25, 2014 and the final on February 25, 2015. The options vested in three annual installments beginning with the first on February 13, 2014, the second on February 13, 2015 and the final on February 13, 2016. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Jon R. Cohen 2017-06-21